Publications
38
Citations
654
Est. group size
~5
Recurring co-author estimate
Active years
26
Publishing since 2000
Qi-En Wang studies how cancer cells, particularly in lung and ovarian cancer, become resistant to treatment and maintain 'stemness' - a state that allows a subset of tumor cells (cancer stem cells) to resist therapy and drive tumor regrowth. This work spans DNA damage repair pathways, epigenetic and microRNA regulation, and signaling pathways (such as STAT, ERK, and immune checkpoint pathways) that control cancer stem cell behavior and treatment resistance. The research aims to find therapeutic strategies that target these resistant cancer cell populations.
Publication output has remained modest and fairly steady over the last decade, fluctuating between one and four papers per year without a clear long-term upward or downward trend.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Regulation of Cancer Stem Cells in the Tumor Microenvironment
Cancer Heterogeneity and Plasticity · 2025
- PPP2R2A insufficiency enhances PD-L1 immune checkpoint blockade efficacy in lung cancer through cGAS-STING activation
Journal of Clinical Investigation · 2025
- ALDH and cancer stem cells: Pathways, challenges, and future directions in targeted therapy
Life Sciences · 2024
- Abstract 2447: XPC suppresses cancer stem cells via inhibiting STAT1-mediated expression of SOX2 in NSCLC
Cancer Research · 2023
- Abstract 2428: Cancer stem cells maintain stemness via autocrine activation of the IFN/JAK/STAT signaling pathway
Cancer Research · 2023
- ERK inactivation enhances stemness of NSCLC cells via promoting Slug-mediated epithelial-to-mesenchymal transition
Theranostics · 2022
- DNA Damage Response and Cancer Metastasis: Clinical Implications and Therapeutic Opportunities
Exon Publications eBooks · 2022
- Abstract 3325: ERK inhibitor increases cancer stem cell population in NSCLC through Slug-Mediated epithelial-to-mesenchymal transition
Cancer Research · 2022
- Abstract 1519: ALDH1A1 enhances micro homology-mediated end joining by increasing POLQ expression
Cancer Research · 2022
- Aberrant expression of TMEM205 signaling promotes platinum resistance in ovarian cancer: An implication for the antitumor potential of DAP compound
Gynecologic Oncology · 2021
- MiRNA-200C expression in Fanconi anemia pathway functionally deficient lung cancers
Scientific Reports · 2021
- Abstract 3094: Estrogen receptor β agonist depletes ovarian cancer stem cells via repressing epithelial to mesenchymal transition
Cancer Research · 2021
- Bioinformatics analysis of miRNAs identifies enrichment of axon guidance pathway genes in ovarian cancer stem cells
2021 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · 2021
- Ouabain regulates kidney metabolic profiling in rat offspring of intrauterine growth restriction induced by low-protein diet
Life Sciences · 2020
- Metabolomics analysis identifies lysine and taurine as candidate prognostic biomarkers for AML-M2 patients
International Journal of Hematology · 2020
- Cancer Research×9
- Life Sciences×2
- PLoS ONE×2
- Figshare×2
- Oncotarget×1
- Ananya Banerjee
Medicine · The Ohio State University
- Subramanyam Dasari
Medicine · Indiana University
- Seung-Oe Lim
Medicine · Purdue University West Lafayette
- Zhe Li
Medicine · Purdue University West Lafayette
- Vasudha Shukla
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile